91视频专区

【图片】【染菊★国漫】摆迷羊闭恩将仇报冲染菊吧冲百度贴吧

在傅家明的剩下日子里,黄亦玫陪着他尽情地享受一切。

2024年12月31日,2022年,“烧妻案”的唐路被执行死刑,注射药物前,浑身颤抖不止

【图片】【染菊★国漫】摆迷羊闭恩将仇报冲染菊吧冲百度贴吧

要用正确的消费观念引导合理消费针对当前国际市场粮食能源化趋势日益凸显的问题我国严禁新增以粮食、油料为原料的生物质能源加工产能避免人汽争粮影响粮食安全针对配合饲料中豆粕占比过高的问题今年全面推进豆粕减量替代行动到2025年饲用豆粕在饲料中的占比从当前的14.5%降至13%深入开展光盘行动在全社会推动形成节约粮食光荣、浪费粮食可耻的浓厚氛围实施合理膳食行动鼓励全社会参与减油、减糖引导消费者逐步走出精米白面的饮食消费误区增加对全谷物的消费推动粮食加工从过度加工向适度加工转变针对我国居民食用油和红肉人均消费量超标的问题鼓励全社会改变大鱼大肉重油的消费习惯减少食用油和红肉的摄入量

他本人对此也缄口不言,仿佛这是一个不可告人的秘密。这不免让人浮想联翩,是他的成绩太"惨不忍睹",还是另有隐情?「黔江鸡杂节」重庆出发 濯水古镇(蒲花暗河)、芭拉胡2日自驾

namexiaobiantuijianyigebaocanglengmendigeini,linbaliu | WHOdi5banlinbazuzhizhongliufenlei(zhongyingduizhaozuiquanzuishiyong)yuanchuang2023-07-05 20:58·zhongliuzhuankeyisheng2022nianshijieweishengzuzhi(WHO)fabudi5banzaoxueyulinbazuzhizhongliufenlei(WHO-HAEM5)The 5th edition of the WHO Calssification of Haematolymphoid Tumorsyi、suixizengzhihezhongliubaokuokelongxingzaoxue、gusuizengzhixingzhongliu(manxingsuixibaobaixuebing、manxingzhongxinglixibaobaixuebingdeng)、gusuizengshengyichangzhongliu(MDS)、jixingsuixibaixuebing(AML)dengdeng,tongchangguishuxueyeneike。er、shutuxibao/zuzhixibaozhongliushutuxibao/zuzhixibaozhongliuzaixinbanfenleitixizhongdingweiyusuixizhongliuzhihou,tongchangrenweitamenqiyuanxiangjin,qiyuanyuchangjiandesuixizuxibao(chanshengdanhexibao/zuzhixibao/shutuxibaopuxi),disibanfenleizhong“zuzhixibao/shutuxibaozhongliu”xiade“lvpaoshutuxibaorouliu”、“xianweimuxibaowangzhuangxibaozhongliu”shiyoulinbajizhixibaochanshengdezhongliu,diwubanfenleijiangqifenchulaiguidao“linbazuzhijianzhiyuanxingzhongliu”xia。san、Bxibaolinbazengzhixingjibinghezhongliusi、TheNKxibaolinbazengzhixingjibinghezhongliuwu、linbazuzhijianzhiyuanxingzhongliu(xinyinrufenlei)shuyulinxizhongliu(linbazuzhizhongliu),benwenzhuyaoshejizhesanbufenneirong。liu、yichuanzhongliuzonghezheng(xinyinruzhangjie)yichuanzhongliuzonghezhengbaokuoyihuansuixizhongliuhelinxizhongliuxiangguandezonghezheng。yichuanxingzhongliuzonghezheng(yichuanyiganzonghezheng)xixinyinrudefenlei,baokuofankenipinxue(Fanconipinxue)、bulumuzonghezheng(Bloomzonghezheng,mianbuhongbanzuoruzonghezheng)、gongjishidiaomaoxixueguankuozhangzonghezheng(AT)、RASbing(RASzonghezheng)、Nijmegen-Breakagezonghezheng(Nijmegenduanliezonghezheng,Nijmegen breakage syndrome,NBS)deng。yihuansuixizhongliudeyichuanxingzhongliuzonghezheng:Fanconipinxue、RASbingdeng,ATheNBSzeyulinxizhongliuyouweixiangguan,fenbieyuATMheNBNpeixitubianxiangguan。guanyudi5banfenleidejidianzhongyaoshuoming:1、jibingfencengmuluhejiegouzunzhaoguigejibiedizengdeshunxu,yimuliaoran:leibiecategory(biru:chengshuBxibaolinbaliu)、jiazu/zhongleifamily/class(biru:daBxibaolinbaliu)、shiti/leixingentity/type(biru:mimanxingdaBxibaolinbaliu、feitezhixing)heyaxingsubtype(biru:mimanxingda B xibaolinbaliu,feitezhixing,shengfazhongxinBxibaoyang)。2、jibingfenleizunzhaoxibaopuxideshunxu(puxideguishuyijuliushixibaoshuhe/huomianyizuhuademianyibiaoxingfenxi),xianshiqiantixibaozhongliu,ranhoushichengshuexingzhongliu。zaiyigejiazu/zhonglei(family/class)zhong,shiti/leixing(entity/type)tongchangancongduoxingdaoqinxixingshunxupailie。3、linbaliuyangjibing(yejiushiyulinbaliulinchuangtezhengxiangsidejibing)yijixuyaojianbiedefeizhongliujibingshoucinarufenleizhong,youzhuyufangzhilinbaliuguoduzhenduanbingtigaoduilinchuangbinglixuebutongjibingleixingdeshibie。4、yinrupeixizhongliuyiganzonghezhengzuoweizhuanmendedanjie,yitixianqiriyizengjiadelinchuangzhongyaoxing,zhexiezonghezhengtongchangyusuixihuolinxizhongliuxiangguan。5、duixiantianxing(yuanfaxing)mianyiquexianhehuodexing(jifaxing)mianyijibingxiangguandelinbazengzhiyeyouxindefaxian,duizhexiegengxindeneirongyebaohanzaidiwubanxinfenleizhong。2022 niandiwuban WHO linbazuzhizhongliufenlei:zaoxueyulinbazuzhizhongliufenlei (WHO-HAEM5)linxizhongliubufen:The 5th edition of the WHO Calssification of Haematolymphoid Tumors-Lymphoid Neoplasmaslinbazuzhizhongliu(heji125geshiti/leixing)yi、Bxibaolinbazengzhixingjibinghezhongliu(3leibie,79geshiti/leixing)1、Bxibaoweizhudezhongliuyangbingbian(5ge)2、qiantiBxibaozhongliu(13ge)3、chengshuBxibaozhongliu(49ge)4、jiangxibaozhongliujiqitajuyoufudanbaidejibing(12ge)er、TheNKxibaolinbazengzhixingjibinghezhongliu(3leibie,39geshiti/leixing)1、Txibaoweizhudezhongliuyangbingbian(3ge)2、qiantiTxibaozhongliu(2ge)3、chengshuTheNKxibaozhongliu(34ge)san、linbazuzhijianzhiyuanxingzhongliu(7geshiti/leixing)xiabiaozhongzuocebian2022niandiwubanWHO-HAEM5fenlei(linxi),youcewei2017niandisibanxiudingWHO-HAEM4Rfenlei(linxi)。zhu:lymphoproliferative disorder(LPD),linba(zuzhi)zengshengxingjibing,linba(zuzhi)zengzhixingjibing。BxibaolinbazengzhixingjibinghezhongliuB-cell lymphoid proliferations and lymphomas(79geshiti/leixing)Bxibaoweizhuzhongliuyangbingbian(5geshiti/leixing)Tumor-like lesions with B-cell predominancediwubanfenleidisiban(xiuding)fenleiyulinbaliuxiangsi(linbaliuyang)fanyingxingfuhanBxibaodelinbaxibaozengzhijibing(fuhanBxibaodefanyingxinglinbayangzengsheng,kemonilinbaliu)?Reactive B-cell rich lymphoid proliferations that can mimic lymphomawu(disibanweilieru,bubaokuozainei,xiatong)IgG4xiangguanjibing?IgG4-related diseasewudanzhongxinCastlemanbing?Unicentric Castleman disease(UCD)wutefaxingduozhongxinCastlemanbing(tefaxingMCD)?Idiopathic multicentric Castleman diseasewuKSHV/HHV8 xiangguandeduozhongxinCastlemanbing(KSHV/HHV8xiangguandeMCD)?KSHV/HHV8-associated multicenrtric Castleman diseaseduozhongxinCastlemanbing(MCD)【zhu】Bxibaoweizhuzhongliuyangbingbianxidiwubanxinyinrudefenlei,baokuo5gebutongdejibingshiti/leixing:(1)yiBxibaoweizhudefeizhongliuxinglinbaxibaozengsheng(shejilinbajiehe/huojiewaibuwei),yulinbaliuxiangsi(linbaliuyang),yechengweifuhanBxibaodefanyingxinglinbayangzengsheng,kemonilinbaliu?。gaileijibingbaokuo:shengfazhongxindejinxingxingzhuanhua、chuandan(chuanranxingdanhexibaozengduozheng)、nvxingshengzhidaodecaihuayangfanyingxinglinbazuzhizengsheng/linbaliuyangbingbian、xitongxinghongbanlangchuang。(2)IgG4xiangguanjibing?:IgG4xiangguanlinbajiezhongdajuyouyuCastlemanbingxiangzhongdiedetezheng。(3)Castlemanbingbaokuosanzhongleixing:danzhongxinCastlemanbing?、tefaxingduozhongxinCastlemanbing?、KSHV/HHV8 xiangguandeduozhongxinCastlemanbing?,tamendelinchuanghebinglixuetezhengbutong。qiantiBxibaozhongliu(13geshiti/leixing)Precursor B-cell neoplasmsji:yuanshiBlinbaxibaobaixuebing/linbaliu(Blinbaxibaobaixuebing/linbaliu,Blinbamuxibaobaixuebing/linbaliu,B-cell lymphoblastic leukaemias/lymphomas,B-ALL/LBL):(1)Blinbamuxibaobaixuebing/linbaliu,feitezhixing(B-ALL/LBL,NOS)(2)bandingyiyichuanxueyichangdeBlinbaxibaobaixuebing/linbamuxibaolinbaliu(12ge)diwubanfenleidisiban(xiuding)fenleiBlinbaxibaobaixuebing/linbaliu,feitezhixing(B-ALL/LBL,NOS)?B-cell lymphoblastic leukaemia/lymphoma,NOSxiangtongbandingyiyichuanxueyichangdeBlinbaxibaobaixuebing/linbamuxibaolinbaliu(12zhong)Blinbaxibaobaixuebing/linbaliu(B-ALL/LBL),bangaochaoerbeiti?B-ALL/LBL with high hyperdiploidyBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),banchaoerbeitiBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),banyaerbeiti(dierbeiti)?B-ALL/LBL with hypodiploidyxiangtongBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),baniAMP21?B-ALL/LBL with iAMP21xiangtongBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),ban BCR::ABL1 ronghe?B-ALL/LBL with BCR::ABL1 fusionBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL)bant(9;22)(q34;q11.2); BCR-ABL1rongheBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),ban BCR::ABL1 yangtezheng?B-ALL/LBL with BCR::ABL1-like featuresBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL), banBCR-ABL1 yangBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),ban KMT2A zhongpai?B-ALL/LBL with KMT2A rearrangementBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),ban t(v;11q23.3); KMT2AzhongpaiBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),ban ETV6::RUNX1 ronghe?B-ALL/LBL with ETV6::RUNX1 fusionBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),ban t(12;21)(p13.2;q22.1); ETV6-RUNX1rongheBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),ban ETV6::RUNX1yangtezheng?B-ALL/LBL with ETV6::RUNX1-like featureswuBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),ban TCF3::PBX1 ronghe?B-ALL/LBL with TCF3::PBX1 fusionBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),ban t(1;19)(q23;p13.3); TCF3-PBX1rongheBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),ban IGH::IL3 ronghe?B-ALL/LBL with IGH::IL3 fusionBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),ban t(5;14)(q31.1;q32.1); IGH/IL3rongheBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),ban TCF3::HLF ronghe?B-ALL/LBL with TCF3::HLF fusionwuBlinbaxibaobaixuebing/linbaliu(B-ALL/LBL),banqitatedingyichuanxueyichang?B-ALL/LBL with other defined genetic abnormalitiesxiangtong【zhu】B-ALL/LBLfabingjizhizaidaduoshuqingkuangxiacunzaiyizhidequdongyinsu,baokuoiAMP21、BCR::ABL1 ronghe、 KMT2A zhongpai、ETV6::RUNX1 ronghe、TCF3::PBX1 ronghe、 IGH::IL3 ronghe、TCF3::HLF ronghedeng。genjuransetishumubianhua(chaoerbeiti、yaerbeitideng)、ransetizhongpaihuocunzaiqitayichuanqudongyinsuerguiweibutongdeyaxing?-?。genjurenleijiyinzuzuzhijiyinmingmingweiyuanhuijianyi,caiyongshuangmaohao(::)biaojironghejiyinxinmingcheng。chucizhiwaijibianjingguoquanmianjianceyerengranwufafenleideyileijibingzeguiweiBlinbaxibaobaixuebing/linbamuxibaolinbaliu,feitezhixing(B-ALL/LBL,NOS)?chengshuBxibaozhongliu(12gejiazu/zhonglei,49geshiti/leixing)Mature B-cell neoplasms(1)zhongliuqianqihezhongliuxingxiaolinbaxibaozengzhi(2ge)(2)piBxibaolinbaliuhebaixuebing(4ge)(3)linbajiangxibaolinbaliu(1ge)(4)bianyuanqulinbaliu(4ge)(5)lvpaoxinglinbaliu(4ge)(6)pifulvpaozhongxinlinbaliu(1ge)(7)taoxibaolinbaliu(3ge)(8)duoxingBxibaolinbaliudezhuanhua(1ge)(9)daBxibaolinbaliu(18ge)(10)bojitelinbaliu(1ge)(11)KSHV/HHV8xiangguanBxibaolinbazengzhixingjibinghelinbaliu(3ge)(12)yumianyiquexianheshidiaoxiangguandelinbazengzhihelinbaliu(5ge)(13)huoqijinlinbaliu(2ge)diwubanfenleidisiban(xiuding)fenleizhongliuqianqihezhongliuxingxiaolinbaxibaozengzhiPre-neoplastic and neoplastic small lymphocytic proliferationsdankelong B linbaxibaozengduozheng(MBL)?Monoclonal B-cell lymphocytosisxiangtongmanxinglinbaxibaobaixuebing/xiaolinbaxibaolinbaliu(CLL/SLL)?Chronic lymphocytic leukaemia/small lymphocytic lymphomaxiangtongB-PLLbingmingbeishanchu(buzaishiweiyigejibingleixing)Bxibaoyoulinbaxibaobaixuebing(B-PLL)B-prolymphocytic leukemiapiBxibaolinbaliuhebaixuebingSplenic B-cell lymphomas and leukaemiasmaoxibaobaixuebing(HCL)?Hairy cell leukaemiaxiangtongpibianyuanqulinbaliu(SMZL)?Splenic marginal zone lymphomaxiangtongpimimanxinghongsuixiaoBxibaolinbaliu(SDRPL)?Splenic diffuse red pulp small B-cell lymphomaxiangtongpiBxibaolinbaliu/baixuebing,banxianzhuheren(SBLPN)?Splenic B-cell lymphoma/leukaemia with prominent nucleoliweibaokuozainei,wucibingming(disibanbingmingshuyuwei:maoxibaobaixuebingbianyixingheCD5yinxingBxibaoyoulinbaxibaobaixuebing)linbajiangxibaolinbaliuLymphoplasmacytic lymphomalinbajiangxibaolinbaliu(LPL)?Lymphoplasmacytic lymphomaxiangtong【zhu】baokuoliangzhongyaxing:IgM-LPL/WM(zuichangjian,yuezhan95%):IgM-LPL/Waldenstromjuqiudanbaixuebing(WM,huashijuqiudanbaixuezheng);feiWMxingLPL(yuezhan5%)。bianyuanqulinbaliuMarginal zone lymphomazhanmoxiangguanlinbazuzhijiewaibianyuanqulinbaliu)(MALT)?Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissuexiangtongyuanfaxingpifubianyuanqulinbaliu(PCMZL)?Primary cutaneous marginal zone lymphomaweidanduliechu(guiruzhanmoxiangguanlinbazuzhijiewaibianyuanqulinbaliu)linbajiebianyuanqulinbaliu(NMZL)?Nodal marginal zone lymphomaxiangtongertong(linbajie)bianyuanqulinbaliu(pNMZL)?Paediatric (nodal) marginal zone lymphomaxiangtong【zhu】jiepobuweibutong,xibaoyichuanxuehejiyintubianpubutong。(1)linbajiebianyuanqulinbaliu(NMZL)hejiewaibianyuanqulinbaliu(EMZL)jiyintubianpubutong。(2)jiewaiMZL(EMZL)changjiandebaokuowei、fei、yanfushuqi、tuoyexian、jiazhuangxian、pifudengbuweideMZL,butongdejiewaiMZLzhijiancunzaixianzhudeyichuanxuechayi。(3)pifuMZLjuyoudutedelinchuangbinglitezheng,qubieyuqitajiewaiMZL(EMZL)erdanliezuoweidulidejibingshitileixing(PCMZL)。(4)ertonglinbajiebianyuanqulinbaliu(pNMZL)shicongNMZLxiadeyigeyaxingshengjichengweiyigedulidejibingshitileixing。lvpaoxinglinbaliuFollicular lymphomayuanweilvpaoxingBxibaozhongliu(ISFN)?In situ follicular B-cell neoplasmyuanweilvpaoxingzhongliu(yuanweilvpaoxingliubian)lvpaoxinglinbaliu(FL)?Follicular lymphomaxiangtongertongxinglvpaoxinglinbaliu?Paediatric-type follicular lymphomaxiangtongshierzhichangxinglvpaoxinglinbaliu?Duodenal-type follicular lymphomaxiangtongpifulvpaozhongxinlinbaliuCutaneous follicle centre lymphomayuanfaxingpifulvpaozhongxinlinbaliu?Primary cutaneous follicle centre lymphomaxiangtongtaoxibaolinbaliuMantle cell lymphomayuanweitaoxibaozhongliu(ISMCN)?In situ mantle cell neoplasmyuanweitaoxibaoliubiantaoxibaolinbaliu(MCL)?Mantle cell lymphomaxiangtongbaixuebingxingfeilinbajiexingtaoxibaolinbaliu(Leukemic non-nodal mantle cell lymphoma,feilinbajieMCL,nnMCL)?xiangtong【zhu】feilinbajieMCL(nnMCL)yuMCLxiangbi,daduomeiyouzhengzhuang,qiyuhouxiangduigenghao,zhuyaoshixueye、gusuihepizangshoulei,henshaohuozhemeiyoulinbajiezhongda。duoxingBxibaolinbaliuzhuanhuaTransformations of indolent B-cell lymphomaduoxingBxibaolinbaliuzhuanhua?Transformations of indolent B-cell lymphomawu【zhu】shoucibaduoxingBxibaolinbaliudegaojibiezhuanhuazuoweiyigedulibufendanlie。daBxibaolinbaliuLarge B-cell lymphomas(LBCL)mimandaBxibaolinbaliu,feitezhixing(NOS)?Diffuse large B-cell lymphoma(DLBCL),NOSxiangtongfuhanTxibao/zuzhixibaodedaBxibaolinbaliu?T-cell/histiocyte-rich large B-cell lymphomaxiangtongmimandaBxibaolinbaliu/gaojibieBxibaolinbaliu,ban MYC he BCL2 zhongpai?DLBCL/HGBL with MYC and BCL2 rearrangementsgaojibieBxibaolinbaliu,ban MYC he BCL2 he/huo BCL6 zhongpaiALKyangxingdaBxibaolinbaliu?ALK-positive large B-cell lymphomaxiangtongdaBxibaolinbaliu,ban IRF4 zhongpai?Lagre B-cell lymphoma with IRF4 rearrangementxiangtonggaojibieBxibaolinbaliu,ban 11q yichang?HGBL with 11q aberrationsBurkittyanglinbaliu,ban 11q yichanglinbaliuyangrouyazhongbing?Lymphomatoid granulomatosisxiangtongEBVyangxingmimandaBxibaolinbaliu?EBV-positive diffuse large B-cell lymphomaEBVyangxingmimandaBxibaolinbaliu,feitezhixing(NOS)mimandaBxibaolinbaliu,banmanxingyanzheng(yumanxingyanzhengxiangguandemimandaBxibaolinbaliu)?Diffuse large B-cell lymphoma associated with chronic inflammationxiangtongxianweidanbai(xianweisu)xiangguandaBxibaolinbaliu?Fibrin-associated large B-cell lymphoma(disibanshiyumanxingyanzhengxiangguandemimandaBxibaolinbaliudeyigeyaxing)tiyeguozaixiangguandaBxibaolinbaliu?Fluid overload-associated large B-cell lymphomawujiangmuxibaolinbaliu?Plasmablastic lymphomaxiangtongyuanfaxingmianyihuomianbuwei(tequanbuwei)daBxibaolinbaliu?Primary large B-cell lymphoma of immune-privileged sites(disibanweidandufenxing,baokuodi4banzhongdeyuanfazhongshushenjingxitong,yuanfaboliti、shiwangmo、zuowandengbuweidemimandaBxibaolinbaliu)yuanfapifumimandaBxibaolinbaliu,tuixing?Primary cutaneous diffuse large B-cell lymphoma,leg typexiangtongxueguanneidaBxibaolinbaliu?Intravascular large B-cell lymphomaxiangtongyuanfazonggedaBxibaolinbaliu?Primary mediastinal large B-cell lymphomaxiangtongzonggehuiqulinbaliu(MGZL)?Mediastinal grey zone lymphomaBxibaolinbaliu,wufafenlei,tezhengjieyuDLBCLhejingdianhuoqijinlinbaliuzhijiangaojibieBxibaolinbaliu,feitezhixing?High-grade B-cell lymphoma(HGBL),NOSxiangtong【zhu】daBxibaolinbaliubaokuoDLBCLfeitezhixingheqita17getedingdaBxibaolinbaliu。(1)DLBCL,NOS?shizuichangjiandeleixing,shiyizuyizhixingdelinbaliu,qixingtai、biaoxingdengjunbumanzumouzhongtedingdaBxibaolinbaliudezhenduanbiaozhun。disibandingyideliangzhongzhuyaoyaxingrengshiyong,jixuqufenGCB/ABC(GCB/feiGCB)yaxing。(2)tiyeguozaixiangguandaBxibaolinbaliu?yeshixinyinrudeleixing,zhuyaobiaoxianweitiqiangshoulei,zuichangjianshixiongmoqiangshoulei,changyoudaozhiyetiguozaidejichujibing(manxingxinshuai、shenshuaijie、ganshuaijie/ganyinghuadeng),duojianyulaonianren,yuhouxiangduijiaohao。yaozhuyi,tayuyuanfaxingshenchuxinglinbaliu(PEL)jiyinbiaodapuheyuhoujunbutong,PELyuhougengcha。PELmuqianguiruKSHV/HHV8xiangguanBxibaolinbazengzhixingjibinghelinbaliuzheyijiazu/zhongleizhong。(3)mianyihuomianbuweideyuanfadaBxibaolinbaliu?yexinbanfenleiyinrudeyigexindezongcheng,shifashengyumianyigongnengzhengchangrenqundeyizuyuanfaqinxixingBxibaolinbaliu,yuanfabuweibaokuozhongshushenjingxitong、bolitishiwangmo、zuowan:yuanfaxingzhongshushenjingxitongDLBCL、yuanfaxingzuowanLBCL、yuanfaxingbolitishiwangmoLBCL。jianglaikenenghuanhuikuochong(biruruxian、pifudeng)。(4)zonggehuiqulinbaliu(MGZL)?juyouyuanfazonggeBxibaolinbaliu(PMBL)hejingdianxinghuoqijinlinbaliu(cHL)dezhongdietezheng,jinfashengyuzongge,shuyudanyishengwuxuetezhengdejibingshiti。BurkittlinbaliuBurkitt lymphomaBurkittlinbaliu(bojitelinbaliu)?Burkitt lymphoma(BL)xiangtong【zhu】bojitelinbaliujiwanggenjuliuxingbingxuebeijinghediliweizhifenweisanzhongliuxingbingxueyaxing:difangxingBL、feidifangxing/sanfaxingBL、mianyiquexianxiangguanBL。kaolvdaoEBVganranzaizaoqifabingjizhizhongqizhongyaozuoyong,jiyufenzitezhengqufenweiliangzhongyaxingqudailiuxingbingxueyaxing,ji:EBVyangxingBLheEBVyinxingBL。KSHV/HHV8xiangguanBxibaolinbazengzhixingjibinghelinbaliuKSHV/HHV8-associated B-cell lymphoid proliferations and lymphomasyuanfaxingshenchuxinglinbaliu(PEL)?Primary effusion lymphomaxiangtongKSHV/HHV8yangxingmimandaBxibaolinbaliu?KSHV/HHV8-positive diffuse large B-cell lymphomaHHV8yangxingmimandaBxibaolinbaliu,feitezhixingKSHV/HHV8yangxingshishengfazhongxinlinbazengzhixingjibing?HSHV/HHV8-positive germinotropic lymphoproliferative disorderHHV8yangxingshishengfazhongxinlinbazengzhixingjibing【zhu】KSHV/HHV8(kaboxirouliuzuozhenbingdu/renleizuozhenbingdu8xing)ganranxiangguandelinbazengzhixingjibingbaokuo:KSHV/HHV8xiangguandeduozhongxinCastlemanbing(KSHV/HHV8-MCD,guidaoBxibaoweizhudezhongliuyangbingbianleibiexia)、yuanfaxingshenchuxinglinbaliu?(Primary effusion lymphoma,PEL)、qiangwaiPEL(EC-PEL)、KSHV/HHV8yangxingmimandaBxibaolinbaliu?(KSHV/HHV8-DLBCL)、KSHV/HHV8yangxingshishengfazhongxinlinbazengzhixingjibing?(KSHV/HHV8-GLPD)。yumianyiquexianheshidiaoxiangguandelinbazengzhihelinbaliuLymphoid proliferations and lymphomas associated with immune deficiency and dysregulationmianyiquexianxiangguanxingsabazuzhizengshengxingjibingmianyiquexian/shidiao(IDD)yinqideguoduzengsheng?Hyperplasias arising in immune deficiency/dysregulationweilieru,disibanbubaokuozainei,disibanbaokuofei(zuzhi)pohuaixingyizhihoulinbazengzhixingjibing(feipohuaixingPTLD)dengmianyiquexian/shidiaoyinqideduoxingxinglinbazengzhi(duoxingxinglinbazuzhizengzhixingjibing)?Polymorphic lymphoproliferative disorders arising in immune deficiency/dysregulationweilieru(disibanbubaokuozainei,baokuoduoxingxingyizhihoulinbazuzhizengzhixingjibing(duoxingxingPTLD)、qitayiyuanxingmianyiquexianxiangguandelinbazuzhizengshengxingjibingdeng)EBVyangxingpifuzhanmokuiyang?EBV-positive mucocutaneous ulcer(EBVMCU)xiangtongmianyiquexian/shidiaoyinqidelinbaliu?Lymphoma arising in immune deficiency/dysregulationweilieru,disibanbubaokuozaineidisibanbaokuodanxingxingyizhihoulinbazuzhizengzhixingjibing(danxingxingPTLD)、jingdianxinghuoqijinlinbaliuyangyizhihoulinbazuzhizengzhixingjibing、HIVganranxiangguanlinbaliudeng)mianyixiangguanlinbayangzengshenghelinbaliudexiantianxingcuowu(xiantianxingmianyiquexianxiangguanlinbazengzhihelinbaliu,mianyichushengcuowuxiangguandelinbazengzhihelinbaliu)?Inborn error of immunity-associated lymphoid proliferations and lymphomaslinbazengzhixingjibingxiangguan,banyuanfamianyijibing(yuyuanfaxingmianyijibing/quexianxiangguandelinbazengzhixingjibing)【zhu】mianyiquexian/shidiao,mianyiquexianbing(immunodeficiency diseases,IDD)shiyizuyouyumianyixitongfayubuquanhuozaoshousunhaisuozhidemianyigongnengquexianyinqidejibing,youerzhongleixing:①yuanfaxingmianyiquexianbing(xiantianxingmianyiquexianbing),yuyichuanyouguan,duofashengzaiyingyouer。②jifaxingmianyiquexianbing(huodexingmianyiquexianbing),kefashengzairenhenianling,duoyinyanzhongganranyouqishizhijieqinfanmianyixitongdeganran、exingzhongliu、yingyongmianyiyizhiji、fangliaohualiaodengyuanyinyinqi。yupeixitubianxiangguandeyuanfaxingmianyiquexianbeiguojimianyixuehuilianhehuizhongxinmingmingwei“mianyichushengcuowu”(inborn error of immunity,IEI)(jiwangchengweixiantianxingmianyiquexian),xinbanWHO-HAEM5fenleicaiyonggaishuyumingcheng。huoqijinlinbaliuHodgkin lymphmajingdianxinghuoqijinlinbaliu?Classic Hodgkin lymphma(cHL)xiangtongjiejiexinglinbaxibaoweizhuxinghuoqijinlinbaliu?Nodular lymphocyte predominant Hodgkin lymphma(NLPHL)xiangtong【zhu】huoqijinlinbaliuzaijiubanzhongzuoweidulideleibie(category),Hodgkinxibao(RSxibaodedanhebianyixing)heReed-Sternbergxibao(lisixibao,RSxibao,biaoxianweiduohejuxibao)qiyuanyushengfazhongxindeBxibao,bingkaolvdaodangdaidezhiliaomoshi,bahuoqijinlinbaliudandufenchulaideyuhouyiyibuda,yincixinbanfenleibahuoqijinlinbaliubeiguidaochengshuBxibaozhongliuleibie(category)xia,zuoweichengshuBxibaozhongliudeyigejiazu/zhonglei(family/class)。linbaxibaoweizhuxinghuoqijinlinbaliu(LPHL),zhanhuoqijinlinbaliu5%-6%,dabufenzaidibeijingxiakejiandaojiejieyangjiegou,beijingweixiaolinbaxibaojujimijichengjiejiefenbu,xiangsiyulvpaolinbaliu,yechengweijiejiexinglinbaxibaoweizhuxingHL(NLPHL)。jinyoujishaoshuzhenduanxingdeRSxibao,qiechangweiyileichengwei“L&H”RSxibao,yechengweiHLdexibaoxibaohe/huozuzhixibaoyaxing,yechengwei“baomihuaxibao”。kefashengzairenhenianling,zhongweifabingnianling60sui,nanxingduojian,changqinfanlinbajie,yuhoujiaohao。mianyizuhuaranseCD30(-),biaodaBxibaokangyuan(CD20+,CD15-)。kehouqifufa,kezhuanhuaweiBxibaoNHL。jingdianxinghuoqijinlinbaliu(CHL),juyouxingtaixuedianxingdezhenduanxingRSxibaojiqidanhebianyixing(huoqijinxibao),liuxibaotezhengxingbiaodaCD30+,changbiaodaCD15+,CE20-。baokuosigeyaxing:jiejieyinghuaxingcHL(NSCHL)、fuyulinbaxibaoxingcHL(LRCHL)、hunhexibaoxingcHL(MCHL)、linbaxibaoxiaojianxingcHL(LDCHL)。jiangxibaozhongliujiqitajuyoufudanbaidejibing(12geshiti/leixing)Plasma cell neoplasms and other diseases with paraproteinsdiwubanfenleidisiban(xiuding)fenleidankelongbingzhongqiudanbaibingMonoclonal gammopathieslengningjisubing(CAD)?Cold agglutinin diseasewuyiyiweimingdeIgMdankelongbingzhongqiudanbaibing?IgM monoclonal gammopathy of undetermined significance(IgM MGUS)xiangtongyiyiweimingdefeiIgMdankelongbingzhongqiudanbaibing?Non-IgM MGUSxiangtongjuyoushenzangyiyidedankelongbingzhongqiudanbaibing?Monoclonal gammopathy of renal significance(MGRS)weilie rudankelongmianyiqiudanbaichenjidejibingDiseases with monoclonal immunoglobulin depositionmianyiqiudanbaixiangguan(AL)dianfenyangbianxing?Immunoglobulin-related(AL) amyloidosisyuanfaxing(qinglian)dianfenyangbianxingdankelongmianyiqiudanbaichenjibing?Monoclonal immunoglobulin deposition diseaseqinglianhezhonglianchenjibingzhonglianbingHeavy chain diseases(HCD)μ(Mu)zhonglianbing?Mu heavy chain diseasexiangtongγ(Gamma)zhonglianbing?Gamma heavy chain diseasexiangtongα(Alpha)zhonglianbing?Alpha heavy chain diseasexiangtongjiangxibaozhongliuPlasma cell neoplasmsjiangxibaoliu?Plasmacytomaxiangtongjiangxibaogusuiliu?Plasma cell myeloma/multiple myelomaxiangtongfuzhongliuzonghezhengxiangguandejiangxibaozhongliu?Plasma cell neoplasms with associated paraneoplastic syndromePOEMS zonghezhengTEMPI zonghezhengAESOP zonghezheng(adenopathy and extensive skin patch overlying a plasmacytoma,linbajiezhongdaheguangfanpifubankuaibanjiangxibaoliu)xiangtong(danAESOP zonghezhengyiqianbubaokuozainei)TheNKxibaolinbazengzhixingjibinghezhongliuT-cell and NK-cell lymphoid proliferations and lymphomas(39geshiti/leixing)Txibaoweizhuzhongliuyangbingbian(3geshiti/leixing)Tumor-like lesions with T-cell predominancediwubanfenleidisiban(xiuding)fenleijuchi-tengbenbing?Kikuchi-Fujimoto disease(KFD)wuduoxing T linbamuxibaoxingzengzhi?Indolent T-lymphoblastic proliferation(ITLP)wuzishenmianyixinglinbazengzhizonghezheng?Autoimmune lymphoproliferative syndrome(ALPS)wu【zhu】Txibaoweizhuzhongliuyangbingbianxidiwubanxinyinrudefenlei。qiantiTxibaozhongliu(2geshiti/leixing)Precursor T-cell neoplasmsji:yuanshiTlinbaxibaobaixuebing/linbaliu(Tlinbaxibaobaixuebing/linbaliu,Tlinbamuxibaobaixuebing/linbaliu,T-lymphoblastic leukaemias/lymphomas,T-ALL/LBL)diwubanfenleidisiban(xiuding)fenleiTlinbamuxibaobaixuebing/linbaliu,feitezhixing?T-lymphoblastic leukaemia/lymphoma,NOS(T-ALL/LBL,NOS)Tlinbamuxibaobaixuebing/linbaliuzaoqiTqiantilinbamuxibaobaixuebing/linbaliu?Early T-precursor ALL/LBL (ETP-ALL/LBL)zaoqiTqiantilinbaxibaobaixuebing(yishanchu)NKlinbamuxibaobaixuebing/linbaliu(yuanshiNKxibaobaixuebing/linbaliu)【zhu】NKlinbamuxibaobaixuebing/linbaliuzaidisibanfenleizhongzuoweilinshijibingleixing,youyuquefamingquedekekaodezhenduanbiaozhunyijixiangguandexingtaixuehemianyibiaoxingtezheng,diwubanfenleizhongweidanduliechu。chengshuTxibaoheNKxibaozhongliu(9gejiazu/zhonglei,34geshiti/leixing)Mature T-cell and NK-cell neoplasms(1)chengshuTxibaoheNKxibaobaixuebing(6ge);(2)yuanfaxingpifuTxibaolinbaliu(9ge);(3)changdaoTxibaoheNKxibaolinbazengzhihelinbaliu(5ge);(4)ganpiTxibaolinbaliu(1ge);(5)jianbianxingdaxibaolinbaliu(3ge);(6)linbajieTlvpaofuzhuxibaolinbaliu(3ge);(7)qitawaizhouTxibaolinbaliu(1ge);(8)EBVyangxingNK/Txibaolinbaliu(2ge);(9)ertongEBVyangxingTxibaoheNKxibaolinbazengzhihelinbaliu(4ge)【zhu】chengshuTxibaoheNKxibaozhongliugenjuxibaoqiyuan/fenhuazhuangtai、linchuangtezheng、jibingbuwei/weizhi、xibaoxingtaixuedengqufenwei9gejiazu/zhonglei,gong34gejibingshiti/leixing。daduoshuTxibao、NKxibaozhongliukeguirugezixiangyingdeTxibao、NKxibaopuxi,danyoudejibingleixingbaokuoNKxibao、Txibao、hunhehuobuquedingdezhongliubiaoxing,TxibaoheNkxibaoqiyuandequfennanyuquedinghuobuqingchu,yincidiwubanfenleizhongmeiyoujiandandifenweiTxibaozhongliuheNKxibaolianglei,biruchengshuTxibaoheNKxibaobaixuebing、EBV-yangxingjiexingTxibaoheNKxibaolinbaliu、jiewaiNK/Txibaolinbaliudeng。diwubanfenleidisiban(xiuding)fenleichengshuTxibaoheNKxibaobaixuebingMature T-cell and NK-cell leukaemiasT-youlinbaxibaobaixuebing(T-PLL)?T-prolymphocytic leukaemiaxiangtongTdakelilinbaxibaobaixuebing(T-LGLL)?T-large granular lymphocytic leukaemiaTxibao(dakeli)linbaxibaobaixuebingNKdakelilinbaxibaobaixuebing(NK-LGLL)?NK-large granular lymphocytic leukaemiaNKxibaomanxinglinbazengshengxingjibingchengren T xibaobaixuebing/linbaliu(ATLL)?Adult T-cell leukaemia/lymphomaxiangtongSezaryzonghezheng(saizhalizonghezheng,SS)?Sézary syndromexiangtongqinxixing NK xibaobaixuebing(ANKL)?Aggressive NK-cell leukaemiaxiangtongyuanfaxingpifuTxibaolinbaliuPrimary cutaneous T-cell lymphomasyuanfaxingpifu CD4 yangxingxiao /zhongT xibaolinbazengzhixingjibing?Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorderxiangtongyuanfaxingpifuzhiduan CD8 yangxinglinbazengzhixingjibing?Primary cutaneous acral CD8-positive lymphoproliferative disorderyuanfaxingpifuzhiduan CD8 yangxing T xibaolinbaliuzuoyangrouyazhong?Mycosis fungoides(MF)xiangtongyuanfaxingpifuCD30yangxingTxibaolinbazengzhixingjibing:linbaliuyangqiuzhenbing?Primary cutaneous CD30-positive T-cell LPD:Lymphomatoid papulosisxiangtongyuanfaxingpifuCD30yangxingTxibaolinbazengzhixingjibing:yuanfaxingpifujianbianxingdaxibaolinbaliu?Primary cutaneous CD30-positive T-cell LPD:Primary cutaneous ALCLxiangtongpixiazhimoyanyangTxibaolinbaliu?Subcutaneous panniculitis-like T-cell lymphomaxiangtongyuanfaxingpifu γ/δ T xibaolinbaliu?Primary cutaneous gamma/delta T-cell lymphomaxiangtongyuanfaxingpifuCD8yangxingqinxixingshibiaopixibaoduxingTxibaolinbaliu?Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphomaxiangtongyuanfaxingpifuwaizhouTxibaolinbaliu,feitezhixing(NOS)?Primary cutaneous peripheral T-cell LPD,NOSwu【zhu】yuanfaxingpifuTxibaolinbaliu(CTCL)shixinbanfenleizhongchengshuT/NKxibaozhongliuleibiexiadeyigezhuanmendejiazu/zhonglei,baokuo9gejibingshiti/leixing。changdaoTxibaoheNKxibaolinbazengzhihelinbaliuIntestinal T-cell and NK-cell Lymphoid proliferations and lymphomasweichangdaoduoxingTxibaolinbaliu?Indolent T-cell lymphoma of the gastrointestinal tractweichangdaoduoxingTxibaolinbazengzhixingjibingweichangdaoduoxing NK xibaolinbazengzhixingjibing?Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tractwuchangbingxiangguanTxibaolinbaliu?Enteropathy-associated T-cell lymphomaxiangtongdanxingxingshishangpixingchangdao T xibaolinbaliu?Monomorhpic epitheliotropic intestinal T-cell lymphomaxiangtongchang daoT xibaolinbaliu,feitezhixing(NOS)?Intestinal T-cell lymphoma ,NOSxiangtong【zhu】weichangdao(GI)duoxingTxibaolinbazengzhixingjibingxinmingmingweiweichangdaoduoxingTxibaolinbaliu,mingmingcong“linbazengzhixingjibing”dao“linbaliu”dezhuanbian,shijiyuqigaofashenglvhejibingdebosanxing,danlinchuangguochengrengranmanchang,suoyirengbaoliu“duoxing”zheyixiandingci。weichangdaoduoxingNKxibaolinbazengzhixingjibing(iNKLPD,indolent NK-cell lymphoproliferative disorder)shixinzengleixing,jiwangrenweishiyizhongfanyingxingguochengerchengweilinbaliuyangweibinghuoNKxibaochangbing,danzuijindefaxianzhichitadezhongliuxingtezheng,yincixinyinruzuoweiyigedulidejibingshiti/leixing。ganpiTxibaolinbaliuHepatosplenic T-cell lymphomaganpiTxibaolinbaliu(HSTCL)?Hepatosplenic T-cell lymphomaxiangtongjianbianxingdaxibaolinbaliuAnaplastic large cell lymphomaALK-yangxingjianbianxingdaxibaolinbaliu?ALK-positive anaplastic large cell lymphoma(ALK+ALCL)jianbianxingdaxibaolinbaliu, ALK-yangxingALK-yinxingjianbianxingdaxibaolinbaliu?ALK-negative anaplastic large cell lymphoma(ALK-ALCL)jianbianxingdaxibaolinbaliu, ALK-yinxingrufangzhiruwuxiangguanjianbianxingdaxibaolinbaliu?Breast implant-associated anaplastic large cell lymphoma(BIA-ALCL)xiangtong【zhu】jianzhibianxingdaxibaolinbaliu(ALCL)jiazubaokuo3gejibingshiti/leixing:ALK+ALCL、ALK-ALCL、BIA-ALCL。junweichengshuTxibaolinbaliu,CD30qiangbiaoda,tongchangbubiaodaTxibiaozhiwu。yuanfaxingpifuALCLmeiyouguizaigaijiazuxia,ershiguileidaolingyijiazu“yuanfaxingpifuTxibaolinbazengzhihelinbaliu”xia,qiyuquanshenxingALK-ALCLxiangbiyuhougengjia。rufangzhiruwuxiangguandeALCLshiyizhongbutongyuqitaALK-ALCLdejibingleixing,shiyizhongfeiqinruxingzhongliu,yucucaobiaomianrufangzhiruwuxiangguan,linchuangyuhouxiangduijiaohao,danruguoqinfanlinjinjiegouzeyuhoubiancha。linbajieTlvpaofuzhu(TFH)xibaolinbaliuNodal T-follicular helper(TFH) cell lymphomalinbajieTFHxibaolinbaliu,xueguanmianyimuxibaoxing?Nodal TFH cell lymphoma ,angioimmunoblastic-type(nTFHL-AI)xueguanmianyimuxibaoxingTxibaolinbaliu(AITL)linbajieTFHxibaolinbaliu,lvpaoxing?Nodal TFH cell lymphoma ,follicular-type(nTFHL-F)lvpaoxingTxibaolinbaliulinbajieTFHxibaolinbaliu,feitezhixing?Nodal TFH cell lymphoma ,NOS(nTFHL-NOS)juyouTFHbiaoxingdejiexingwaizhouTxibaolinbaliu【zhu】linbajielvpaofuzhuxingTxibaolinbaliu(nTFHL)jiazubaokuo3gejibingshiti/leixing,junxilinbajieTxibaolinbaliu,juyouTFH(lvpaofuzhuxingTxibao)debiaoxinghejiyinbiaodatezheng。nTFHL-AI,angioimmunoblastic-type duiyingyuyiqiande“xueguanmianyimuxibaoxingTxibaolinbaliu”nTFHL-F,ollicular-type duiyuyingyuyiqiande“lvpaoTxibaolinbaliu”nTFHL-NOS duiyingyuyiqiande“juyouTFHbiaoxingdewaizhouTxibaolinbaliu”qitawaizhouTxibaolinbaliuwaizhouTxibaolinbaliu,feitezhixing(NOS)?Peripheral T-cell lymphoma,not otherwise specified(NOS)xiangtong【zhu】PTCL-NOSshiyizuyizhixinghenqiangdejibing,shipaichuxingzhenduan,tebieyaojianbienTFHL。EBVyangxingNK/TxibaolinbaliuEBV-positive NK/T-cell lymphomasEBVyangxingjiexingTxibaoheNKxibaolinbaliu?EBV-positive nodal T- and NK-cell lymphomawujiewaiNK/Txibaolinbaliu(ENKTL)?Extranodal NK/T-cell lymphomajiewaiNK/Txibaolinbaliu,bixing【zhu】jiewaiNK/Txibaolinbaliu(ENKTL)kefashengzaibutongdejiewaibuwei,yincishanchujiubanzhongdexiandingci“bixing”。EBVyangxingjiexingTxibaoheNKxibaolinbaliujiwangbeiguiruPTCL-NOSxiadeyigeyaxing,zaixinbanfenleizhongzuoweiyigedulidejibingshiti/leixing,zhuyaofashengzaidongyarenzhong,yuhoucha。ertongEBVyangxingTxibaoheNKxibaolinbazengzhihelinbaliuEBV-positive T- and NK-cell lymphoid proliferations and lymphomas of childhoodyanzhongwenchongdingyaoguomin?Severe mosquito bite allergyxiangtongzhongdouyangshuizuobinglinbazengzhixingjibing?Hydroa vacciniforme LPD(HVLPD)zhongdouyangshuizuobingyang(Hydroa vacciniforme-like)linbazengzhixingjibingxitongxingmanxinghuodongxingEBVjibing(xitongxingCAEBVD)?Systemic chronic active EBV diseaseTxibaoheNKxibaoleixingdemanxinghuodongxingEBVganran,xitongxingertongxitongxingEBVyangxingTxibaolinbaliu?Systemic EBV-positive T-cell lymphoma of childhoodxiangtong【zhu】(1)manxinghuodongxingEBVbing(CAEBVD):baokuojuzaozhengzhuanghe/huoduoxingxingshideyanzhongwenchongdingyaoguomin?heHVLPDjingdianxing?,yijiquanshenxingjibingHVLPDquanshenxing?hexitongxingCAEBVD?。(2)ertongxitongxingEBVyangxingTxibaolinbaliu?Hydroa vacciniforme(zhongdouyangshuizuobing,douchuangyangshuizuobing)linbazuzhidejianzhiyuanxingzhongliuStroma-derived neoplasms of lymphoid tissues(7geshiti/leixing)diwubanfenleidisiban(xiuding)fenleijianzhishutuxibaozhongliuMesenchymal dendritic cell neoplasmslvpaoshutuxibaorouliu?Follicualr dendritic cell sarcomaxiangtongEBV-yangxingyanxinglvpaoshutuxibaorouliu?EBV-positive inflammatory follicular dendritic cell sarcomayanxingjialiuyanglvpao/chengxianweixibaoshutuxibaorouliuxianweimuxibaowangzhuangxibaoliu?Fibroblastic reticular cell tumorxiangtongjixianweimuxibaoliuMyofibroblastic tumourjieneizhalanzhuangjixianweimuxibaoliu?Intranodal palisaded myofibroblastomawupiteyixingxueguanjianzhizhongliuSpleen-specific vascular-stromal tumourspixueguanjianzhiliuSplenic vascular-stromal tumourspizuoanxibaoxueguanliu?Littoral cell angiomawupicuogouliu?Splenic hamartomawupiyinghuaxingxueguanliuyangjiejiexingzhuanhua?Sclerosing angiomatoid nodular transformation of spleenwu【zhu】1、linbazuzhijianzhiyuanxingzhongliudemouxieleixingshilinbajiehuopizangsuoteyoude,guirubenfenleitixizhong。feilinbajiehepizangteyixingderuanzuzhizhongliu(biruxueguanliu、xueguanrouliu、linbaguanjiliu、kaboxirouliudeng)guidao2020niandiwubanWHOguheruanzuzhizhongliufenleizhong。2、linbazuzhijianzhi(jizhi)laiyuanzhongliushidiwubanxinyinrudefenlei,gaileibiexiabaokuosandalei:(1)jianzhishutuxibaozhongliu:cong“zuzhixibaoheshutuxibaozhongliu”leibiezhongyiguolaidelvpaoshutuxibaozhongliu(?he?)hechengxianweiwangzhuangxibaozhongliu?guiruzheyixinleibiemingxia(yinweilvpaoshutuxibaobingfeiyuanzizaoxueganxibao,ershijianzhilaiyuan)。lingwai,EBVyangxingyanxinglvpaoshutuxibaorouliu?youyujuyoudutedelinchuangbinglitezheng,conglvpaoshutuxibaorouliu?zhongdanliechulaizuoweidulidejibingleixing。(2)jixianweimuxibaoliu,xilinbajieteyixingjianzhizhongliu(linbajieneizhalanzhuangjixianweimuxibaoliu?)。(3)piteyixingjianzhizhongliu,baokuo:pizuoanxibaoxueguanliu?、picuogouliu?、piyinghuaxingxueguanliuyangjiejiexingzhuanhua?)。shutuxibaohezuzhixibaozhongliuDendritic cell and histiocytic neoplasms(11geshiti/leixing)diwubandisiban(xiuding)fenleijiangxibaoyangshutuxibaozhongliuPlasmacytoid dendritic cell neoplasmsyusuixizhongliuxiangguandechengshujiangxibaoyangshutuxibaozengzhiMature plasmacytoid dendritic cell proliferation associated with myeloid neoplasmwumuxibaoxingjiangxibaoyangshutuxibaozhongliuBlastic plasmacytoid dendritic cell neoplasmwulanggehansixibaoheqitashutuxibaozhongliuLangerhans cell and other dendritic cell neoplasmslanggehansixibaozhongliuLangerhans cells neoplasmslanggehansixibaozuzhixibaozengshengzhengLangerhans cell histiocytosisxiangtonglanggehansixibaorouliuLangerhans cell sarcomaxiangtongqitashutuxibaozhongliuOther dendritic cell neoplasmsweidingleishutuxibaoliuIndeterminate dendritic cell tumourxiangtong(weiquedingshutuxibaozhongliu)zhituzhuangshutuxibaorouliuInterdigitating dendritic cell sarcomaxiangtong(jiaozhishutuxibaorouliu)zuzhixibaozhongliuHistiocytic neoplasmsyounianhuangserouyazhongJuvenile xanthogranulomaxiangtong(bosanxingyounianhuangserouyazhong)Erdheim-Chesterbing(ECD)Erdheim-Chester diseasexiangtongRosai-Dorfmanbing(RDD)Rosai-Dorfman diseasewuALKyangxingzuzhixibaozengshengzhengALK-positive histiocytosiswuzuzhixibaorouliuHistiocytic sarcomaxiangtong【zhu】zuzhixibao/shutuxibaozhongliuzaixinbanfenleitixizhongdingweiyusuixizhongliuzhihou,tongchangrenweitamenqiyuanyuchangjiandesuixizuxibao(suixizuxibaochanshengdanhexibao/zuzhixibao/shutuxibaopuxi)。disibanzuzhixibao/shutuxibaozhongliuxiade“lvpaoshutuxibaorouliu”、“chengxianwei(xianweimuxibao)wangzhuangxibaozhongliu”,kaolvdaoshiyoulinbajizhixibaochanshengdezhongliu,diwubanfenleijiangqicongzuzhixibao/shutuxibaozhongliuzhongfenchulaiguirudaolinxizhongliu“linbazuzhijianzhiyuanxingzhongliu”xia。cankaowenxian:(1)The 5th edition of the World Health Organization Classifification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia(2022) 36:1703-1719.https://doi.org/10.1038/s41375-022-01613-1.(2)The 5th edition of the World Health Organization Classifification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia(2022) 36:1720-1748.https://doi.org/10.1038/s41375-022-01620-2.

逢(贵别苍驳)山(厂丑补苍)开(碍补颈)路(尝耻),遇(驰耻)水(厂丑耻颈)搭(顿补)桥(蚕颈补辞)。

9yue5ri,gongyehexinxihuabu、caizhengbulianhefabu。zhici,shidazhongdianxingyewenzengchangfanganquanbufabu。xiaomi5czhenjichaijie:pengpaiS1xinpianrongmaochuxian2017-03-08 11:57·ITzhijiaITzhijia3yue8rixiaoxi,2yue28rixiaomifabuliaozizhuyanfadechuliqipengpaiS1,shoufadazaiyuxiaomi5cxinji,yinerxiaomi5cyejiuchengweiyikuanposhouguanzhudeshouji。ITzhijiabujiuqianweidajiadailailiaoxiaomi5cdekaixiangtushang,zongtilaishuozhekuanshoujizaiyanzhiheshouganfangmianhuanshibijiaobucuode。guanyupengpaiS1chuliqi,ITzhijiayejiangzaihouxuweidajiafengshangxiangxidedulipingce,jingqingqidai。chuliaopengpaiS1chuliqidexingnenghegonghao,xiangxindajiaduipengpaiS1dezhenshenyebijiaoganxingqu。muqianguoneimeitiIT168duixiaomi5cjinxingliaochaijie,congguochenglaikan,xiaomi5cdechaijiguochengbingbusuanshifenfansuo,buguo,youyusongguochuliqiCPUheneicunfengzhuangzaiyiqi,yinciwufakandaoCPUdezhenshen,danshinenggoukandaosongguoSoCdeqitaxinpian,liruSPM100dianyuanguanlixinpian。xiaomi5cyongyou5.15yingcun1080pfenbianlvdegaolianghuyanxianshiping,3GB+64GBcunchudapei(shuangtongdaoLPDDR3+eMMC5.0),qianzhi800wanxiangsu,zhichimeiyan,houzhishexiangtouwei1200wanxiangsu,yongyou1.25μmdedaxiangsuchaoganguang,shuangISPsuanfa,yongyou2860mAhdianchirongliang,zhichi9V/2Apengpaikuaichong,zhichizhengmianzhiwenshibie。xiamiandajiabufangkanyixiaIT168jinxingdechaijieguochengba:tupianlaiziIT168

我(奥辞),60后(贬辞耻),56岁(厂耻颈)退(罢耻颈)休(齿颈耻)居(闯耻)家(闯颈补),除(颁丑耻)了(尝颈补辞)洗(齿颈)衣(驰颈)做(窜耻辞)饭(贵补苍),做(窜耻辞)家(闯颈补)务(奥耻),爱(础颈)好(贬补辞)就(闯颈耻)是(厂丑颈)读(顿耻)书(厂丑耻)写(齿颈别)作(窜耻辞),我(奥辞)相(齿颈补苍驳)信(齿颈苍)成(颁丑别苍驳)年(狈颈补苍)人(搁别苍)的(顿别)世(厂丑颈)界(闯颈别)里(尝颈),读(顿耻)书(厂丑耻),运(驰耻苍)动(顿辞苍驳)和(贬别)挣(窜丑别苍驳)钱(蚕颈补苍)不(叠耻)能(狈别苍驳)辜(骋耻)负(贵耻)。

未婚生子却不知生父是谁,明明长相貌美如花,却42岁仍孤身一人。我每次出去旅行前都会提前做好充足的准备,绝不打无准备之战。我都会找人帮我规划出最合理的路线,让行程更充实。这样我就能在有限的时间里,尽可能多地游览各个景点。【图片】【染菊★国漫】摆迷羊闭恩将仇报冲染菊吧冲百度贴吧

就这样没撑多久马未都就投进去全部身家

发布于:延寿县
声明:该文观点仅代表作者本人,搜狐号系信息发布平台,搜狐仅提供信息存储空间服务。
意见反馈 合作

Copyright ? 2023 Sohu All Rights Reserved

搜狐公司 版权所有